Literature DB >> 18468767

Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification.

Soraya Carrancio1, Natalia López-Holgado, Fermín M Sánchez-Guijo, Eva Villarón, Victoria Barbado, Soraya Tabera, María Díez-Campelo, Juan Blanco, Jesús F San Miguel, M Consuelo Del Cañizo.   

Abstract

OBJECTIVE: Optimization of the mesenchymal stem cells (MSC) isolation and expansion method.
MATERIALS AND METHODS: Mononuclear cells (MNC) from bone marrow aspirates were obtained by both density gradient centrifugation (standard method) and gravity sedimentation. Cells were cultured in standard conditions (10% fetal calf serum and normal oxygen tension [21% O(2)]) and expansion results compared to those obtained with the same culture conditions to which platelet lysate (PL) preparations were added; in addition, the 21% O(2) concentration was compared to a lower (5%) concentration (hypoxia) until the fourth cell passage. Time of expansion, number of cells obtained, morphology, cell surface markers, and differentiation potential were evaluated.
RESULTS: MSC obtained by any of the different culture conditions expressed comparable immunophenotype and were able to differentiate into osteoblasts, adipocytes, and chondrocytes. When the number of MSC obtained at fourth passage was analyzed, the highest cell numbers were obtained with gravity sedimentation isolation and PL-supplemented culture and the expansion time was the shortest when cells were cultured under hypoxic conditions.
CONCLUSION: MSC isolation by MNC gravity sedimentation together with culture medium supplementation with 5% of PL in a hypoxic atmosphere (5% O(2)) significantly improved MSC yield and reduced expansion time compared to the standard accepted protocols.

Entities:  

Mesh:

Year:  2008        PMID: 18468767     DOI: 10.1016/j.exphem.2008.03.012

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  43 in total

1.  Comparative effect of human platelet derivatives on proliferation and osteogenic differentiation of menstrual blood-derived stem cells.

Authors:  Somaieh Kazemnejad; Roghaieh Najafi; Amir Hassan Zarnani; Saman Eghtesad
Journal:  Mol Biotechnol       Date:  2014-03       Impact factor: 2.695

2.  Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures.

Authors:  Katharina Schallmoser; Dirk Strunk
Journal:  J Vis Exp       Date:  2009-10-30       Impact factor: 1.355

3.  A Perfusion Bioreactor System for Cell Seeding and Oxygen-Controlled Cultivation of Three-Dimensional Cell Cultures.

Authors:  Jakob Schmid; Sascha Schwarz; Robert Meier-Staude; Stefanie Sudhop; Hauke Clausen-Schaumann; Matthias Schieker; Robert Huber
Journal:  Tissue Eng Part C Methods       Date:  2018-10       Impact factor: 3.056

4.  Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue.

Authors:  Shalini Vellasamy; Pratheep Sandrasaigaran; Sharmili Vidyadaran; Elizabeth George; Rajesh Ramasamy
Journal:  World J Stem Cells       Date:  2012-06-26       Impact factor: 5.326

5.  Comparison of isolation and expansion techniques for equine osteogenic progenitor cells from periosteal tissue.

Authors:  Laurie A McDuffee
Journal:  Can J Vet Res       Date:  2012-04       Impact factor: 1.310

6.  Current applications of mesenchymal stem cells for tissue replacement in otolaryngology-head and neck surgery.

Authors:  Suzanne N King; Summer E Hanson; Peiman Hematti; Susan L Thibeault
Journal:  Am J Stem Cells       Date:  2012-11-30

7.  Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.

Authors:  Carlos Santamaría; Sandra Muntión; Beatriz Rosón; Belén Blanco; Olga López-Villar; Soraya Carrancio; Fermín M Sánchez-Guijo; María Díez-Campelo; Stela Alvarez-Fernández; María E Sarasquete; Javier de las Rivas; Marcos González; Jesús F San Miguel; María Consuelo Del Cañizo
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

Review 8.  Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics.

Authors:  Antonio Garcia-Gomez; Fermin Sanchez-Guijo; M Consuelo Del Cañizo; Jesus F San Miguel; Mercedes Garayoa
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

Review 9.  Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience.

Authors:  Eva Rubio-Azpeitia; Isabel Andia
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

10.  Human bone marrow-derived mesenchymal stem cells display enhanced clonogenicity but impaired differentiation with hypoxic preconditioning.

Authors:  Lisa B Boyette; Olivia A Creasey; Lynda Guzik; Thomas Lozito; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.